Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD? Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019
A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial Source: Eur Respir J, 58 (3) 2004522; 10.1183/13993003.04522-2020 Year: 2021
Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study Source: Eur Respir J, 51 (5) 1702523; 10.1183/13993003.02523-2017 Year: 2018
Late Breaking Abstract - Blood eosinophil counts and treatment response in COPD: analyses of IMPACT Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS Year: 2018
Impact of blood eosinophil variability in asthma: a real-life population study. Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Are peripheral blood eosinophil counts a guideline for omalizumab treatment? STELLAIR says no! Source: Eur Respir J, 51 (5) 1800730; 10.1183/13993003.00730-2018 Year: 2018
Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016
Late Breaking Abstract - Blood eosinophil count (EOS) can accurately predict responsiveness to inhaled corticosteroids (ICS) in COPD, but only if measured while patients are not receiving steroids. Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS Year: 2018
Late Breaking Abstract - Blood eosinophil count and exacerbation history in COPD: pooled analysis of 24,103 patients Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019
Blood EOSinophil counts in asthmatic patients in Italy (EOS study) Source: International Congress 2017 – Biomarker-based asthma control Year: 2017
Association between blood eosinophil count and control of allergic rhinitis: does it exist? Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019
High eosinophil counts predict decline in FEV1 : results from the CanCOLD study Source: Eur Respir J, 57 (5) 2000838; 10.1183/13993003.00838-2020 Year: 2021
Late Breaking Abstract - The blood eosinophils count as a predictor of the response for omalizumab (OMA) in patients suffering from severe allergic asthma Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019
Blood eosinophil (EOS) count, exacerbation rate and response to roflumilast in patients with severe COPD Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017
Asthma treatment based on sputum cell counts or usual clinical outcomes: the LOMA study Source: Eur Respir J 2003; 22: Suppl. 45, 35s Year: 2003
Peripheral blood eosinophil counts in COPD patients and its relationship with prescription of inhaled corticosteroid in real world setting in Japan. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017
Adherence to omalizumab: a “real-life” study Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019
Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS) Source: International Congress 2018 – Eosinophils in airway disease Year: 2018
Determinants of blood eosinophil count in adults from a large population-based study Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021
Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis Source: Eur Respir J, 59 (1) 2004590; 10.1183/13993003.04590-2020 Year: 2022